Cas No.: | 945721-28-8 |
pH value: | Corresponds to reference standard: PASS |
Non-reduced CE-SDS: | 99.1% |
SEC-HPLC: | 99.6% |
Isoelectric Point: | Corresponds to reference standard:PASS |
Bacterial Endotoxins Test: | <1 EU/ml |
Exogenous Residual DNA: | <1 pg/mg |
Residual protein A: | <1 ng/mg |
Biological Activity: | Compared with standard, the range of biological activity is 103% |
Osmolality: | Corresponds to reference standard: PASS |
Peptide mapping: | Corresponds to reference standard: PASS |
N-terminal sequence: | Corresponds to reference standard:PASS |
Description: | Daratumumab is a human monoclonal antibody targeting CD38, an antigen uniformly expressed by plasma cells in multiple myeloma and light-chain amyloidosis (AL). |